%0 Journal Article 
%T Development Of Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutation In Patients With Breast Cancer History: Case Report
%D 2016
%@ 1073-449X
%U http://hdl.handle.net/10906/81355
%X Mutation of exons 19 and 21 encoding for Epidermal Growth Factor Receptor (EGFR) tyrosine Kinase domain, is found in 15-20% of lung adenocarcinomas (NSCLC) and in 0.8-1.4% of breast carcinomas (BC) with negative hormonal receptors. Radiotherapy is considered an indiscriminate activation factor of EGFR. Objetive: To report 2 cases of BC treated with chemo radiotherapy that later developed NSCLC with EGFR mutation
%K Ciencias socio biomédicas
%K Medical sciences
%K Adenocarcinoma
%K Pulmones - Enfermedades
%K Tumor
%K Cáncer de mama
%~ GOEDOC, SUB GOETTINGEN